SEC Connect
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR
15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): August 10,
2017
CHROMADEX CORPORATION
(Exact name of registrant as specified in its
charter)
|
Delaware
|
001-37752
|
26-2940963
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
10005 Muirlands Boulevard, Suite G, Irvine, California,
92618
(Address
of principal executive offices, including zip code)
(949) 419-0288
(Registrant's telephone number, including area
code)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[
]Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
]Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
]Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[
]Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the
registrant is an emerging growth company as defined in
Rule 405 of the Securities
Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of
this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07
Submission
of Matters to a Vote of Security Holders.
On
August 10, 2017, ChromaDex Corporation (the “Company”)
held a Special Meeting of Stockholders (the “Special
Meeting”) at which the Company’s stockholders approved
a proposal to issue shares of the Company’s common stock in
connection with a financing transaction (the
“Transaction”). As of June 19, 2017, the record date
for the Special Meeting, 46,093,894 shares of common stock were
outstanding and entitled to vote at the Special Meeting. At the
Special Meeting, 25,012,872 shares of common stock were present in
person or represented by proxy. Pursuant to NASDAQ listing rules,
shares of common stock owned by Champion River Ventures Limited
(“Champion”) and Pioneer Step Holdings Limited
(“Pioneer”), the purchasers in the Transaction, were
not entitled to vote on the proposal. The shares of common stock
held by Champion and Pioneer were not present in person or
represented by proxy at the Special Meeting.
Set
forth below are the full results of the matter submitted for a vote
of stockholders at the Special Meeting.
Proposal 1 — Approval of Issuance of Common Stock in
Connection with a Financing Transaction.
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
|
24,779,564
|
|
223,926
|
|
9,382
|
|
0
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
CHROMADEX CORPORATION
|
|
|
|
|
|
Dated:
August 14, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/
Thomas C. Varvaro
|
|
|
|
|
|
|
|
Name:
Thomas C. Varvaro
|
|
|
|
|
|
|
|
Chief
Financial Officer
|